Microneedling With Tranexamic Acid: Does It Work for Melasma and Pigmentation?

Microneedling with tranexamic acid has a growing body of research behind it, particularly for melasma and pigmentation. That interests me because most people who undergo microneedling are not doing it simply to put tiny needles into their skin. They want a result: smoother texture, brighter-looking skin, improvement in acne scars, fine lines, pigmentation, melasma, or what many of my South African clients call chubaba.

I am an ardent fan of microneedling. I have been microneedling my own skin for more than ten years, and it is one treatment I can personally vouch for. But being a fan of a treatment does not mean I believe we should microneedle just anything into the skin.

In fact, the more I have learned about formulation and skin biology, the more cautious I have become about what is applied during a microneedling procedure.

One of the things that made me particularly cautious was learning about granulomatous reactions. These reactions appear to be rare, but what caught my attention was that vitamin C, an ingredient most of us regard as perfectly ordinary in skincare, has been implicated in a number of published cases following microneedling.

In one published report, two women developed foreign-body-type granulomas after a vitamin C serum was used during microneedling, and both subsequently had positive patch-test reactions to the serum. Other cases involving vitamin C-containing products have since been reported.

That does not mean applying vitamin C normally to your skin causes granulomas. Nor does it prove that vitamin C itself was responsible for every reported reaction; some of the formulations contained multiple ingredients.

But it reinforced something important for me: applying a cosmetic product to intact skin and introducing a formulation across thousands of freshly created microchannels are not necessarily the same thing.

That sent me down a research rabbit hole. If I was going to formulate a pigmentation-targeting serum specifically for microneedling, which active ingredients had actually been investigated this way?

Tranexamic acid kept appearing. That research eventually led me to formulate the ShaRique Skin Tranexamic Acid Microneedling Serum, a pigmentation-focused serum developed specifically for use alongside microneedling.

Not Studied Doesn’t Mean It Doesn’t Work

A lack of studies does not automatically mean an ingredient doesn’t work.

Many cosmetic ingredients, ingredient combinations and delivery systems simply haven’t been studied in this particular context. Proper clinical research costs money, takes time and requires resources. We cannot assume that everything that hasn’t been studied is ineffective.

The reason I turned so heavily to published research in this case is because microneedling is different. Applying a retinoid, alpha-hydroxy acid or pigmentation serum to intact skin is one thing. Microneedling deliberately creates microscopic channels through the skin barrier.

For me, it wasn’t enough to choose an ingredient simply because I knew it worked well in an ordinary pigmentation serum. I could have formulated different microneedling serums containing alpha-arbutin, vitamin C, kojic acid and other brightening ingredients and tested them myself.

I chose not to take that approach.

When an ingredient is being used alongside a procedure that temporarily disrupts the skin barrier, I would rather start with ingredients researchers have already investigated in that context.

That does not prove tranexamic acid is the only ingredient that can be used alongside microneedling. Nor does it mean every TXA formulation is suitable for microneedling.

What the research gave me was a starting point: human studies in which I could examine the concentrations researchers used, how TXA was delivered, the results they achieved and, just as importantly, the adverse effects they reported.

What Does Tranexamic Acid Actually Do for Pigmentation?

Tranexamic acid — usually shortened to TXA — wasn’t originally developed as a pigmentation treatment. It is a synthetic derivative of the amino acid lysine and has long been used medically to reduce excessive bleeding. Its role in pigmentation came later, when researchers began investigating its effects on biological processes involved in melasma and excess pigmentation.

Melanin itself isn’t the enemy. It gives our skin, hair and eyes their colour and plays an important protective role. Problems arise when the melanocytes, the cells responsible for producing melanin, become overactive and produce or distribute excess pigment in particular areas.

UV exposure, visible light, hormones, inflammation and skin injury can all contribute. This is particularly relevant to melasma, which is far more complicated than simply having “too much melanin”.

One of TXA’s best-known actions in pigmentation involves the plasminogen–plasmin pathway. In simple terms, TXA can interfere with signalling involved in melanocyte activity and excess pigment production. Research also suggests effects involving inflammatory and vascular factors associated with melasma.

And despite the word “acid” in its name, tranexamic acid isn’t an exfoliating acid like glycolic, lactic or mandelic acid. We aren’t trying to peel pigmentation off the surface. We are trying to influence some of the biological processes contributing to excess pigmentation.

Why Combine Microneedling With Tranexamic Acid?

Microneedling already has benefits of its own. The controlled micro-injuries created by the needles initiate a wound-healing response and skin remodelling. That’s one reason microneedling is used for acne scarring, uneven texture and signs of aging.

But the temporary microchannels also create an opportunity for enhanced delivery of substances applied to the skin. That’s where TXA becomes interesting for pigmentation. Researchers have investigated whether microneedling can act both as a treatment itself and as a delivery method for tranexamic acid.

It sounds plausible. But a theory that sounds good on paper isn’t enough for me. What happened when researchers actually tried it on people?

What Do Studies on Microneedling With Tranexamic Acid Actually Show?

Rather than finding one or two small experiments, I found multiple clinical trials and systematic reviews examining TXA with microneedling, particularly for melasma.

A systematic review specifically examining tranexamic acid combined with microneedling reviewed 12 randomised controlled trials and clinical trials. Overall, the authors considered the combination promising for melasma.

But I don’t think we should stop at a review’s conclusion. Let’s look at what researchers actually did.

Microneedling with 5% tranexamic acid

One study involved 60 people with melasma. Researchers compared 1.8% liposomal topical TXA, weekly microneedling with a 5% TXA solution, and 2% hydroquinone. After 12 weeks, all three groups improved. More than 50% improvement was reported in 33.3% of participants receiving microneedling with TXA, compared with 27.8% using liposomal TXA and 30% using hydroquinone. Melanin measurements also decreased significantly.

4% tranexamic acid with microneedling

Researchers have also investigated 4% TXA. One study compared microneedling followed by topical 4% tranexamic acid with 4% hydroquinone. After eight weeks, melasma severity decreased significantly with both approaches. The reduction in modified Melasma Area and Severity Index was approximately 57% in the microneedling + TXA group and approximately 55% in the hydroquinone group.

What about 10% tranexamic acid?

A split-face study involving 40 participants investigated 10% topical tranexamic acid with microneedling. Both sides of each person’s face were microneedled, but researchers applied TXA to one side and distilled water to the other. The TXA-treated side showed substantially greater improvement in melasma severity.

Before anybody reads that and decides that 10% must therefore be better than 5%, stop. The studies used different formulations, needle depths, treatment schedules and protocols. You cannot simply compare percentages between unrelated studies and conclude that the highest concentration wins.

A later randomised controlled trial that included different TXA concentrations reinforces why the relationship isn’t that simple. More is not automatically better.

Not every study found TXA added a significant benefit

This is important. If I’m calling this an evidence-based investigation, I can’t only show you the studies that support the story. A randomised, double-blind, placebo-controlled split-face trial microneedled the entire face and applied TXA to one side and placebo to the other. After three monthly treatments, both sides improved. Melasma severity decreased by approximately 29% on the TXA side and 22% on the control side.

Numerically, TXA performed better, but researchers could not demonstrate a statistically significant difference between the two sides. I don’t find that disappointing. It reminds us that microneedling itself is doing something. We shouldn’t attribute every improvement following a combined treatment to whatever serum happened to be applied.

What Do the Systematic Reviews Say?

Individual clinical trials can be small and use very different protocols. Systematic reviews allow researchers to examine the body of evidence collectively. A systematic review of microneedling with topical agents for melasma included seven randomised clinical trials involving 368 participants. Most investigated tranexamic acid. Overall, melasma severity improved, but researchers also highlighted substantial differences between studies.

More recent reviews have continued to find the TXA/microneedling combination promising while highlighting the need for larger and better-standardised trials.

Microneedling With TXA vs Vitamin C

There is another comparison I found particularly interesting given what initially made me cautious about microneedling serums. Researchers have compared microneedling with tranexamic acid against microneedling with vitamin C for melasma.

A systematic review and meta-analysis found no statistically significant difference between the two approaches in reducing melasma severity. That does not prove the treatments are identical, and it certainly doesn’t mean vitamin C generally causes granulomas.

What it demonstrates is how careful we need to be when interpreting this research. Effectiveness is one question. Formulation and safety are another.

What Strength of Tranexamic Acid Should Be Used?

There isn’t one universally established percentage. Researchers have investigated concentrations including 4%, 5% and 10%, but the protocols differed considerably.

I therefore don’t think the evidence allows us to say: “10% worked in this study, so everyone should use 10%.”

Concentration is only one part of a formulation. And for pigmentation-prone skin, there is another reason not to chase aggressive treatment. One trial reported post-inflammatory hyperpigmentation in participants, with greater concern among darker skin phototypes.

That matters enormously to me. If somebody already has melasma or pigmentation, particularly someone with skin of colour, the objective cannot simply be to deliver as much active ingredient and create as much stimulation as possible. Inflammation itself can contribute to pigmentation. More aggressive isn’t necessarily better.

The Formula Matters as Much as the Percentage

A 5% tranexamic acid everyday facial serum and a 5% TXA formulation used in a microneedling study are not automatically interchangeable. A conventional serum may contain numerous actives, botanical extracts, fragrance, exfoliating acids, penetration enhancers or other ingredients because it was designed to sit on intact skin.

Microneedling changes that environment. This takes me straight back to the granuloma reports. Something being perfectly acceptable when applied normally to the skin does not automatically tell us what happens when a formulation is introduced across a temporarily disrupted skin barrier. That’s why I wasn’t interested in taking one of our existing pigmentation serums and simply relabelling it for microneedling.

What About Acne Marks, Chubaba and Other Pigmentation?

Most of the direct microneedling + TXA evidence we’ve discussed concerns melasma. That distinction is important. Melasma isn’t the only reason people come to me concerned about pigmentation.

There are dark marks left after acne, pigmentation following inflammation or injury, uneven patches of colour and what many people in my South African community call chubaba.

Can we simply take the melasma studies and declare that microneedling + TXA has been clinically proven for all of them? No.

Melasma and post-inflammatory hyperpigmentation can look similar in the mirror, but they’re not necessarily the same condition. However, TXA itself has also been studied for post-inflammatory hyperpigmentation. A systematic review specifically examining tranexamic acid for PIH identified nine studies involving 196 patients, with TXA investigated through several delivery methods.

There is also research involving acne-related dark marks. One randomised trial compared topical 5% TXA with 20% azelaic acid in people with post-acne hyperpigmentation. Both groups improved significantly over 12 weeks.

So there is evidence supporting TXA’s relevance beyond melasma. What we don’t have is the same volume of direct evidence specifically studying microneedling + TXA for post-acne marks as we have for melasma. I think readers deserve to know that difference.

What About Texture, Dullness, Acne Scars and Ageing?

This is where we need to separate what the microneedling is doing from what TXA is doing. Tranexamic acid isn’t the ingredient I would primarily choose to stimulate collagen or remodel an acne scar.

That’s where microneedling comes in. If you are treating acne scars and the dark marks left behind by acne, you effectively have two targets. Microneedling is doing the remodelling. Tranexamic acid is there because pigmentation is also part of the problem.

That also means not everybody who microneedles necessarily needs TXA. If hydration and glide are your primary objectives, a straightforward hydrating microneedling serum may make more sense. If pigmentation, melasma or uneven colour is part of your treatment goal, that’s where TXA becomes particularly interesting.

Can You Use Your Normal Tranexamic Acid Serum for Microneedling?

You already have a TXA serum in your bathroom. It works well on your pigmentation. Can you just apply it and needle over it?

I wouldn’t. And the reason isn’t necessarily the tranexamic acid. It’s everything else that may be in the bottle. An ordinary facial serum was formulated for intact skin. It may contain several active ingredients, botanical extracts, fragrance, essential oils, exfoliating ingredients or other components. That does not automatically make the finished formulation appropriate for use during microneedling.

This is why I don’t look at a bottle and think: “TXA is suitable, therefore this serum is suitable.” I look at the entire formulation.

Why I Kept Our TXA Microneedling Formula Focused

I could easily have created an impressive-looking pigmentation cocktail. Tranexamic acid. Alpha-arbutin. Kojic acid. Vitamin C. Niacinamide. Botanical brighteners. It would sound fantastic on a label.

But that wasn’t my objective. I wasn’t trying to formulate the strongest possible pigmentation serum for intact skin. I was formulating for use alongside a procedure that temporarily disrupts the skin barrier. Those are different formulation objectives.

There are many pigmentation ingredients I like and formulate with in conventional skincare. But I don’t automatically assume that because I am comfortable putting something into a daily serum, I should also use it during microneedling. For this particular product, TXA had something I specifically wanted: published human research in which it had actually been used alongside microneedling. That mattered to me.

Is Microneedling With Tranexamic Acid Risk-Free?

No. I don’t think any responsible discussion about microneedling should describe it as completely safe or risk-free. Microneedling itself can cause temporary redness, swelling and irritation. Potential complications include infection, post-inflammatory hyperpigmentation and, more rarely, scarring and granulomatous reactions.

The TXA studies are encouraging, but many are relatively small and have limited follow-up periods. That means they are much better at detecting common short-term reactions than extremely rare or delayed complications.

There is also an important distinction between topical TXA and oral or injected tranexamic acid. TXA is used medically to reduce bleeding, and systemic administration has contraindications and potential risks requiring appropriate clinical assessment. This article is discussing the research surrounding topical TXA alongside microneedling. It is not a recommendation to take oral tranexamic acid or inject TXA yourself.

How I Approach Microneedling With Tranexamic Acid

After reading all this research, you may wonder whether I simply copied one of the clinical protocols. I didn’t. The studies used different needle depths, intervals, TXA concentrations and delivery methods. Some treatments were performed weekly, others every two or four weeks. These were controlled research or clinical environments.

I take something broader from the evidence. Start with why you are microneedling.

If your primary objective is hydration, glide and general cosmetic microneedling, keep it simple.

If pigmentation or melasma is one of your principal concerns, that’s where a pigmentation-focused approach becomes relevant.

And don’t chase depth. Deeper microneedling creates greater tissue injury and comes with greater responsibility and risk. For pigmentation-prone skin this is particularly important because inflammation itself can stimulate pigmentation. If you’re unsure how far to go, our guide on which needle depth to use on the face walks through it. The objective is controlled stimulation, not seeing how much trauma your skin can tolerate.

Protect the Results You’re Trying to Create

Microneedling and TXA should be part of a pigmentation strategy, not the entire strategy. UV exposure is a major pigmentation trigger, and visible light is particularly relevant to melasma and darker skin tones. Daily broad-spectrum sun protection therefore remains fundamental.

My Conclusion: Does Microneedling With Tranexamic Acid Work?

I started researching tranexamic acid because I wanted to know what I was comfortable formulating for use alongside microneedling. What I found wasn’t one perfect study giving us all the answers.

I found multiple clinical trials. Different concentrations. Different protocols. Comparisons with hydroquinone, vitamin C, placebo and TXA injections. I found systematic reviews bringing those studies together. I also found conflicting results and limitations that shouldn’t be hidden simply because they make the story less exciting.

Taken together, I think the evidence for microneedling with tranexamic acid for melasma is genuinely promising. But promising is the word I deliberately choose. It isn’t a cure for melasma. It isn’t guaranteed to prevent post-inflammatory hyperpigmentation. And the existing research doesn’t prove TXA is the only pigmentation ingredient that could ever be appropriate alongside microneedling.

What the research gave me was confidence in the direction I was taking. Instead of choosing a brightening ingredient simply because it was popular, I could see that researchers had already been investigating tranexamic acid alongside microneedling in human participants. For me, that matters.

It is why I chose tranexamic acid as the pigmentation-focused active for the ShaRique Skin Tranexamic Acid Microneedling Serum.

Whatever you choose, remember the principle that started this entire investigation: don’t assume that because an ingredient is good for your skin, it should automatically be microneedled into your skin.

Frequently Asked Questions